Edition:
United States

Precipio Inc (PRPO.OQ)

PRPO.OQ on NASDAQ Stock Exchange Capital Market

0.69USD
3:59pm EST
Change (% chg)

$-0.04 (-5.61%)
Prev Close
$0.73
Open
$0.73
Day's High
$0.75
Day's Low
$0.60
Volume
28,075
Avg. Vol
11,892
52-wk High
$28.16
52-wk Low
$0.60

Chart for

About

Precipio, Inc., formerly Transgenomic, Inc., is a biotechnology company. The Company is engaged in advancing personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services. The Company operates through its Laboratory Services segment.... (more)
No analyst recommendations are available for .

Overall

Beta: 0.43
Market Cap(Mil.): $7.33
Shares Outstanding(Mil.): 10.03
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 192.73 16.31
EPS (TTM): -- -- --
ROI: -- -0.67 35.74
ROE: -- -3.38 17.71

BRIEF-Precipio Launches Unique Lung Cancer Monitoring Test For Therapy Resistance

* PRECIPIO LAUNCHES UNIQUE LUNG CANCER MONITORING TEST FOR THERAPY RESISTANCE

Feb 15 2018

BRIEF-Precipio Reports Q4 Revenue $945,000

* PRECIPIO ANNOUNCES Q4 2017 REVENUE AT 350% OF PREVIOUS QUARTER

Feb 09 2018

BRIEF-Precipio Enters Into A Purchase Agreement With Leviston Resources

* PRECIPIO SAYS ON FEB 8, CO ENTERED INTO A PURCHASE AGREEMENT WITH LEVISTON RESOURCES TO BUY UP TO $8 MILLION OF SHARES OF CO'S S COMMON STOCK - SEC FILING

Feb 09 2018

BRIEF-Precipio Q3 sales fell 26 percent

* Precipio announces third quarter 2017 financial results and provides corporate update

Nov 20 2017

BRIEF-Precipio Inc files for non-timely 10-Q

* Precipio Inc files for non-timely 10-Q - SEC filing‍​ Source text: (http://bit.ly/2yyJYDg) Further company coverage:

Nov 13 2017

Competitors

  Price Chg
Roche Holding Ltd. (ROG.S) CHF222.05 -1.25
Roche Holding Ltd. (RO.S) CHF225.80 -0.60
Sanofi SA (SASY.PA) €65.05 +0.16
Qiagen NV (QGEN.N) $33.97 +0.41
Sequenom, Inc. (SQNM.OQ) -- --
Merck KGaA (MRCG.DE) €82.34 -0.04

Earnings vs. Estimates